Matrix M H5N1 Vaccine Induces Cross-H5 Clade Humoral Immune Responses in a Randomized Clinical Trial and Provides Protection from Highly Pathogenic Influenza Challenge in Ferrets
Rebecca Jane Cox(Haukeland University Hospital), Haakon Sjursen(Haukeland University Hospital), Laura Campitelli(Istituto Superiore di Sanità), Rishi D. Pathirana(Haukeland University Hospital), Gabriel Kristian Pedersen(Statens Serum Institut), Lucy Breakwell(Centers for Disease Control and Prevention), Kate Guilfoyle(National Institute for Biological Standards and Control), Geir Bredholt(Haukeland University Hospital), Sarah Roseby(National Institute for Biological Standards and Control), Jörg Aßmus(Haukeland University Hospital), Diane Major(National Institute for Biological Standards and Control), Katja Höschler(National Security Agency)
Cited by 18
Related Papers
Animal models for COVID-19
|Nature|2020|877
Generation of influenza vaccine viruses on Vero cells by reverse genetics: an H5N1 candidate vaccine strain produced under a quality system
|Vaccine|2004|156
Reproducibility of Serologic Assays for Influenza Virus A (H5N1)
|Emerging infectious diseases|2009|150
A sensitive retroviral pseudotype assay for influenza H5N1‐neutralizing antibodies
|Influenza and Other Respiratory Viruses|2007|148